Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
International Bullous Diseases Group: Consensus on Diagnostic Criteria for Epidermolysis Bullosa Acquisita Publisher Pubmed



Prostsquarcioni C1, 2, 3 ; Caux F1 ; Schmidt E4 ; Jonkman MF5 ; Vassileva S6 ; Kim SC7 ; Iranzo P8 ; Daneshpazhooh M9 ; Terra J5 ; Bauer J10 ; Fairley J11 ; Hall R12 ; Hertl M13 ; Lehman JS14 Show All Authors
Authors
  1. Prostsquarcioni C1, 2, 3
  2. Caux F1
  3. Schmidt E4
  4. Jonkman MF5
  5. Vassileva S6
  6. Kim SC7
  7. Iranzo P8
  8. Daneshpazhooh M9
  9. Terra J5
  10. Bauer J10
  11. Fairley J11
  12. Hall R12
  13. Hertl M13
  14. Lehman JS14
  15. Marinovic B15
  16. Patsatsi A16
  17. Zillikens D4
  18. Werth V17
  19. Woodley DT18
  20. Murrell DF19
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology and Referral Center for Autoimmune Bullous Diseases, APHP, Avicenne Hospital, Bobigny, France
  2. 2. Department of Histology, UFR Leonard de Vinci, University Paris 13, Bobigny, France
  3. 3. Department of Pathology, APHP, Avicenne Hospital, Bobigny, France
  4. 4. Department of Dermatology, University of Lubeck, Lubeck, Germany
  5. 5. Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
  6. 6. Department of Dermatology, Medical University of Sofia, Sofia, Bulgaria
  7. 7. Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, South Korea
  8. 8. Department of Dermatology, Hospital Clinic de Barcelona, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain
  9. 9. Autoimmune Bullous Diseases Research Center, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Division of Molecular Dermatology, Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria
  11. 11. Department of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center, Iowa City, IA, United States
  12. 12. Department of Dermatology, Duke Medical Center, Durham, NC, United States
  13. 13. Department of Dermatology, University Hospital, Marburg, Germany
  14. 14. Department of Dermatology, Mayo Clinic, Rochester, MN, United States
  15. 15. Department of Dermatology and Venereology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
  16. 16. Second University Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
  17. 17. Department of Dermatology, University of Pennsylvania and Philadelphia Department of Veterans Affairs Medical Center, Philadelphia, PA, United States
  18. 18. Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
  19. 19. Department of Dermatology at St George Hospital, University of New South Wales, Sydney, Australia

Source: British Journal of Dermatology Published:2018


Abstract

Background: Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous disease disease with variable clinical presentations and multiple possible diagnostic tests, making an international consensus on the diagnosis of EBA essential. Objectives: To obtain an international consensus on the clinical and diagnostic criteria for EBA. Methods: The International Bullous Diseases Group (IBDG) met three times to discuss the clinical and diagnostic criteria for EBA. For the final voting exercise, 22 experts from 14 different countries voted on 50 different items. When > 30% disagreed with a proposal, a discussion was held and re-voting carried out. Results: In total, 48 of 50 proposals achieved consensus after discussion. This included nine diagnostic criteria, which are summarized in a flow chart. The IBDG was unable to determine one procedure that would be applicable worldwide. A limitation of the study is that differential diagnosis of bullous systemic lupus erythematosus has not been addressed. Conclusions: This first international consensus conference established generally agreed-upon clinical and laboratory criteria defining the clinical classification of and diagnostic testing for EBA. Holding these voting exercises in person with the possibility of discussion prior to voting has advantages in reaching consensus over Delphi exercises with remote voting. © 2017 British Association of Dermatologists